CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: May 27, 2010
Result type: Reports
Project Number: SR0201-000
Product Line: Reimbursement Review

Generic Name: Tocilizumab

Brand Name: Actemra

Manufacturer: Hoffmann-La Roche Limited

Therapeutic Area: Arthritis, Rheumatoid

Indications: Arthritis, Rheumatoid

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: November 17, 2010

Recommendation Type: List with clinical criteria and/or conditions